• Micro Life Sciences, operating as Meril Life Sciences, achieved significant financial growth in the fiscal year ending March 2025, with revenue increasing by 40.2% to Rs 4,902.9 crore and net profit surging by approximately 119% to Rs 729.4 crore. This performance was likely boosted by increased domestic and export sales of its cardiac device portfolio.
• The company's operating margins improved to 26.4% in FY25 from 20.6% in FY24, attributed to higher operating leverage, a better product mix, and cost efficiencies from backward integration. Improved capacity utilization for its Myval transcatheter heart valve and lower sales and promotion expenses also contributed to these gains.
• Despite strong financial performance, Micro Life Sciences faces potential risks including regulatory challenges and ongoing patent disputes, particularly concerning its Myval transcatheter heart valves. While a US court ruled in its favor, European courts have upheld infringement findings and issued sales bans in member states.
• Looking ahead, Micro Life Sciences is projected to continue its expansion in FY26 with planned capital expenditures of Rs 500-600 crore, funded by debt and internal accruals. The timely execution and ramp-up of expanded capacity are considered key factors for future growth.

Roshan Abraham

Micro Life Sciences Pvt Ltd, a medical device maker backed by global investors such as Abu Dhabi Investment Authority (.........

Bottomline: ADIA-backed Micro Life’s profit doubles; FY26 outlook softens

Others

Healthcare

Micro Life Sciences Pvt Ltd, a medical device maker backed by global investors such as Abu Dhabi Investment Authority (ADIA) and Warburg Pincus, more than...

analysis

bottomline

Micro Life Sciences Pvt Ltd

Abu Dhabi Investment Authority

Warburg Pincus

Bilakhia Group

Meril Life

VC_Desk_Story_Masthead

VC_Desk_Story_A_300x250

VC_Desk_Story_B_300x250

VC_Desk_Story_C_300x250

VC_Desk_Story_D_300x250

VC_Desk_Story_E_300x250

VC_Desk_Story_A_Skyscraper

VC_Desk_Story_B_Skyscraper

VC_Desk_Story_Inline_A_300x250

VC_Desk_Story_Inline_B_300x250

VC_Desk_Story_Inline_C_300x250

VC_Desk_Story_Inline_D_300x250

VC_Desk_Story_Inline_E_300x250

VC_Desk_Story_Footer

Corona Remedies Ltd made a spectacular stock market debut on Monday with shares of the drugmaker that counts private ......

ChrysCap-backed Corona Remedies nears $1 bn valuation after blockbuster debut

Bengaluru-based NU Hospitals Pvt Ltd is in the final stages of closing a funding round that has been in the ......

NU Hospitals in final lap of closing funding round

Baby Memorial Hospital, a multispecialty hospital backed by private equity major KKR & Co, is set to acquire a south ......

KKR set to acquire another South India hospital operator

Fireside Ventures-backed at-home diagnostics firm Inito has raised fresh capital to expand its offerings beyond ......

Fireside Ventures-backed healthtech firm Inito bags $29 mn in Series B

Private equity firm Vixar, which was earlier known as Arpwood Partners and rebranded this year, has acquired a majority ......

PE firm Vixar picks up majority stake in diagnostics firm

Consumer

Infrastructure

Private equity firm KKR, Singapore state investment firm Temasek, venture capital firm Aarin Capital and two other PE ......

KKR, Temasek, three other PE/VC firms move closer to harvesting India bets

Medway Hospitals, a South India-based chain of multi-speciality hospitals, is considering its maiden institutional ......

Bottomline: ADIA-backed Micro Life’s profit doubles; FY26 outlook softens

This is a Premium article. Please subscribe or log in to read the full story!

Related Articles

Healthcare

ChrysCap-backed Corona Remedies nears $1 bn valuation after blockbuster debut

Healthcare

NU Hospitals in final lap of closing funding round

Healthcare

KKR set to acquire another South India hospital operator

Healthcare

Fireside Ventures-backed healthtech firm Inito bags $29 mn in Series B

Healthcare

PE firm Vixar picks up majority stake in diagnostics firm

Consumer

KKR, Temasek, three other PE/VC firms move closer to harvesting India bets

Healthcare

South India-based Medway Hospitals plans first PE round, hires banker

Google News